| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6f4546468d57daf4607bbd7e2904732 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 |
| filingDate |
2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7513ca0c4ddb8088863e4a00995c6867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f80f265fe61852b0a40100238ec6c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29694b552ef5f56589d5f83658b3f7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1eff2f7b74efaf64c7e19fc99fe65ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e5a82b96c81fc5e8a99f4ae76f2064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8394065e9bde2c40dd36dbc05e867701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b42daed53796bbe4dbdf849faff3b32 |
| publicationDate |
2022-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3967758-A1 |
| titleOfInvention |
Materials and methods for treatment of alpha-1 antitrypsin deficiency |
| abstract |
The present application provides materials and methods for treating a patient with alpha-1 antitrypsin deficiency (AATD) both ex vivo and in vivo. In addition, the present application provides materials and methods for editing the SERPINA1 gene in a cell by genome editing. |
| priorityDate |
2015-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |